Duration of anti-CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2-year maintenance paradigm. - Nordkin M; Fadaos N; Leiba R; Sharon-Horesh N; Varon B; Beyar-Katz O; Levi T; Horowitz NA; Tzoran I; Lavi N; Zuckerman T; Dann EJ; et al. (British journal of haematology, 2025)